Cite
Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.
MLA
Huang, Huiping, et al. “Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.” American Journal of Chinese Medicine, vol. 49, no. 2, Feb. 2021, pp. 437–59. EBSCOhost, https://doi.org/10.1142/S0192415X21500208.
APA
Huang, H., Kong, L., Luan, S., Qi, C., & Wu, F. (2021). Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway. American Journal of Chinese Medicine, 49(2), 437–459. https://doi.org/10.1142/S0192415X21500208
Chicago
Huang, Huiping, Lingjin Kong, Shaohua Luan, Chuanzong Qi, and Fanrong Wu. 2021. “Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.” American Journal of Chinese Medicine 49 (2): 437–59. doi:10.1142/S0192415X21500208.